Somaxon, Cereplast gain as drug stocks slip

Two biotech companies break with the general downward trend, rallying on news that they struck partnering deals for their respective products.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.